Wird geladen...
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer
The majority of estrogen receptor (ER)-positive breast cancers are treated with endocrine therapy. While this is effective, acquired resistance to therapies targeted against ER is a major clinical challenge. Here, model systems of ER-positive breast cancers with differential susceptibility to endocr...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2011
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3624623/ https://ncbi.nlm.nih.gov/pubmed/21367843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-10-0262 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|